Current knowledge and research directions in heritable disorders of connective tissue

Matrix Biology

Volumn 15, Issue 4, 1996, Pages 211-229

  Sakai, Lynn Y ^a,f   Burgeson, Robert E ^b   Olsen, Bjorn R ^b   Rowe, David W ^c   Gordon, Stephen L ^d,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d OSIRIS THERAPEUTICS INC   (United States)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDRODYSPLASIA; CONFERENCE PAPER; CONGENITAL SKIN DISEASE; HEREDITARY CONNECTIVE TISSUE DISEASE; HUMAN; MARFAN SYNDROME; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL;

EID: 0030245765     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(96)90113-4     Document Type: Conference Paper

References (12)

1. Anton-Lamprecht I. Ultrastructural identification of basic abnormalities as clues to genetic disorders of the epidermis. J. Invest. Dermatol. 103:1994;6S-12S.
2. Burgeson R.E. Laminins in epidermal structures. Ekblom P., Timpl R. The Laminins. 1996;Harwood Academic Press.
3. Eady R.A.J., McGrath J.A., McMillan J.R. Ultrastructural clues to genetic disorders of the skin: The dermal-epidermal junction. J. Invest. Dermatol. 103:1994;13S-18S.
4. Fenjives E.S. Approaches to gene transfer in keratinocytes. J. Invest. Dermatol. 103:1994;70S-75S.
5. Fuchs E. Intermediate filaments and disease: Mutations that criple cell strength. J. Cell Biol. 125:1994;511-516.
6. Gil S.G., Brown T.A., Ryan M.C., Carter W.G. Junctional epidermolysis bullosis: defects in expression of epiligrin/nice in/kalinin and integrin βB4 that inhibit hemidesmosome formation. J. Invest. Dermatol. 103:1994;31S-38S.
7. Greenhalgh D.A., Rothnagel J.A., Roop D.R. Epidermis: attractive target tissue for gene therapy. J. Invest. Dermatol. 103:1994;63S-69S.
8. Pohla-Gubo G., Lazarova Z., Giudice G.J., Liebert M., Grassegger A., Hintner H., Yancy K.B. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the peridermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp. Dermatol. 4:1995.
9. Roop D. Defects in the barrier. Science. 267:1995;465-474.
10. Rothnagel J.A., Roop D.R. Analysis, diagnosis and molecular genetics of keratin disorders. Curr. Opin. Dermatol. 2:1994;211-218.
11. Sullivan S.M. Development of ribozymes for gene therapy. J. Invest. Dermatol. 103:1994;85S.
12. Uitto J., Pulkkinen L., Christiano A.M. Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin 5) genes. J. Invest. Dermatol. 103:1994;39S-46S.